ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Parnell Pharmaceuticals Holdings Ltd (CE)

Parnell Pharmaceuticals Holdings Ltd (CE) (PARNF)

0.000001
0.00
(0.00%)
Cerrado 27 Noviembre 3:00PM

Herramientas de nivel profesional para inversores individuales.

Estadísticas y detalles clave

Último Precio
0.000001
Postura de Compra
0.00
Postura de Venta
0.00
Volume Operado de la Acción
-
0.00 Rango del Día 0.00
0.000001 Rango de 52 semanas 0.0001
Capitalización de Mercado [m]
Precio Anterior
0.000001
Precio de Apertura
-
Hora
Última hora de negociación
Volumen financiero
-
Precio Promedio Ponderado
-
Volumen promedio (3 m)
250
Acciones en circulación
120,377,529
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
0.00
Beneficio por acción (BPA)
-0.05
turnover
35.43M
Beneficio neto
-5.74M

Acerca de Parnell Pharmaceuticals Holdings Ltd (CE)

Parnell (OTC: PARNF) is a fully integrated pharmaceutical company focused on developing, manufacturing and commercializing innovative animal and human health solutions. Parnell is a technology and clinical science leader in dairy reproduction, marketing its proprietary brands estroPLAN and GONAbreed... Parnell (OTC: PARNF) is a fully integrated pharmaceutical company focused on developing, manufacturing and commercializing innovative animal and human health solutions. Parnell is a technology and clinical science leader in dairy reproduction, marketing its proprietary brands estroPLAN and GONAbreed via its dedicated sales force and digital technology mySYNCH in the USA and Australia-New Zealand, and via distributors in other markets. Parnell has a rapidly growing contract manufacturing business supplying industry majors with specialized sterile injectable products. In companion animal, Parnell manufactures and markets its proprietary canine osteoarthritis brands Zydax and Glyde. For more information on the company and its products, please visit www.parnell.com. Mostrar más

Sector
Pharmaceutical Preparations
Industria
Pharmaceutical Preparations
Sitio web
Sede
Sydney, New South Wales, Aus
Fundado
-
Parnell Pharmaceuticals Holdings Ltd (CE) is listed in the Pharmaceutical Preparations sector of the OTCMarkets with ticker PARNF. The last closing price for Parnell Pharmaceuticals (CE) was US$0. Over the last year, Parnell Pharmaceuticals (CE) shares have traded in a share price range of US$ 0.000001 to US$ 0.0001.

Parnell Pharmaceuticals (CE) currently has 120,377,529 shares in issue. The market capitalisation of Parnell Pharmaceuticals (CE) is US$120.38 . Parnell Pharmaceuticals (CE) has a price to earnings ratio (PE ratio) of 0.00.

PARNF Últimas noticias

Parnell Pharmaceuticals Holdings Ltd Files Form 25, Voluntarily Delisting Its Shares From NASDAQ

OVERLAND PARK, Kan., Dec. 19, 2016 (GLOBE NEWSWIRE) -- Parnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN), a fully integrated, commercial-stage pharmaceutical company focused on developing...

Parnell Pharmaceuticals Holdings Ltd Announces Intention To Move From the NASDAQ OMX Global Market and Expects To Move To the...

OVERLAND PARK, Kan., Dec. 09, 2016 (GLOBE NEWSWIRE) -- Parnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN), a fully integrated, commercial-stage pharmaceutical company focused on developing...

Parnell Pharmaceuticals Holdings Ltd Announces $20 Million Secured Term Loan Facility

OVERLAND PARK, Kan., Nov. 22, 2016 (GLOBE NEWSWIRE) -- Parnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN), a fully integrated pharmaceutical company focused on developing, manufacturing and...

Parnell Pharmaceuticals Holdings Ltd Announces Financial Results for the Nine-Month Period Ended September 30, 2016

OVERLAND PARK, Kansas, Nov. 02, 2016 (GLOBE NEWSWIRE) -- Parnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN), a fully integrated, commercial-stage pharmaceutical company focused on developing...

Parnell to Report Financial Results for the Nine Months Ended September 30, 2016 on November 2, 2016

OVERLAND PARK, Kan., Oct. 27, 2016 (GLOBE NEWSWIRE) -- Parnell Pharmaceuticals Holdings Ltd. (Nasdaq:PARN), a fully integrated pharmaceutical company focused on developing, manufacturing and...

Parnell Pharmaceuticals Holdings Ltd Announces Financial Results for the Six-Month Period Ended June 30, 2016

OVERLAND PARK, Kan., Aug. 04, 2016 (GLOBE NEWSWIRE) -- Parnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN), a fully integrated, commercial-stage pharmaceutical company focused on developing...

Parnell to Report Financial Results for the Six Months Ended June 30, 2016 on August 4, 2016

OVERLAND PARK, Kan., July 26, 2016 (GLOBE NEWSWIRE) -- Parnell Pharmaceuticals Holdings Ltd. (Nasdaq:PARN), a fully integrated pharmaceutical company focused on developing, manufacturing and...

Parnell Pharmaceuticals Holdings Ltd Announces Contract Manufacturing Agreement with Merial

OVERLAND PARK, Kan., May 31, 2016 (GLOBE NEWSWIRE) -- Parnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN), a fully integrated, commercial-stage pharmaceutical company focused on developing...

Parnell Pharmaceuticals Holdings Ltd Announces Pricing of an Underwritten Public Offering of Common Stock

OVERLAND PARK, Kan., May 12, 2016 (GLOBE NEWSWIRE) -- Parnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN), a fully integrated, commercial-stage pharmaceutical company focused on developing...

Parnell Pharmaceuticals Holdings Ltd Announces First Quarter Business Update

Parnell continues to grow rapidly with revenue increasing 43% for the three months ended March 31, 2016OVERLAND PARK, Kan., April 22, 2016 (GLOBE NEWSWIRE) -- Parnell Pharmaceuticals Holdings...

Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
10000000CS
40000000CS
12001.0E-61.0E-61.0E-62501.0E-6CS
26-9.9E-5-990.00010.00011.0E-611754.734E-5CS
52-9.9E-5-990.00010.00011.0E-634467.812E-5CS
156-9.9E-5-990.00010.14821.0E-6101890.00218643CS
260-0.149999-99.99933333330.150.891.0E-6126170.210641CS

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
TMPOQTempo Automation Holdings Inc (CE)
US$ 0.005
(499,900.00%)
100
FUNFFFansUnite Entertainment Inc (CE)
US$ 0.0006
(59,900.00%)
268.14k
SWWISimon Worldwide Inc (GM)
US$ 0.0005
(49,900.00%)
300
AMMJAmerican Cannabis Company Inc (CE)
US$ 0.0004
(39,900.00%)
7.45k
MGTIMGT Capital Investments Inc (CE)
US$ 0.0002
(19,900.00%)
261.83k
CRMBQCrumbs Bake Shop Inc (CE)
US$ 0.000001
(-99.99%)
200
EMWPFEros Media World PLC (CE)
US$ 0.000001
(-99.95%)
100
CNONFLynx Global Digital Finance Corporation (CE)
US$ 0.000001
(-99.90%)
1.85k
DEERDeer Consumer Products Inc (CE)
US$ 0.000001
(-99.90%)
3.6k
CAFSCafe Serendipity Holdings Inc (CE)
US$ 0.000001
(-99.50%)
5k
HMBLHUMBL Inc (PK)
US$ 0.0003
(20.00%)
151.08M
ABQQAB International Group Corporation (PK)
US$ 0.001
(25.00%)
142M
THBDThird Bench Inc (PK)
US$ 0.0001
(0.00%)
128.56M
RDARRaadr Inc (PK)
US$ 0.001
(0.00%)
109.04M
ASTAAstra Veda Corporation (PK)
US$ 0.0002
(0.00%)
93.24M
lovethatgreen lovethatgreen 1 minuto hace
Up another billion wow

This is a waste of time
RDAR
dinogreeves dinogreeves 5 minutos hace
Late in the move, suggesting with the filings, SMCI is going make Hindenburg go bankrupt for trying to run their name through the mud. Big time redemption. Watch for press release tomorrow for the reason to payoff the notes is for financial flexibility. The only thing I want to know, how much mor
SMCI
XenaLives XenaLives 8 minutos hace
B.S. and malfeasance liike this is the simplest expolanation for the heath crisis in this country.

$$$$ are much more important than quality of life or life expectancy of patients....

https://www.biospace.com/drug-development/mercks-former-asthma-blockbuster-singula
Brooge warrants cancelled Brooge warrants cancelled 12 minutos hace
maybe we dipped cause it says blockbuster public offering?
which stomp has been saying for years
FNMA
lodas lodas 14 minutos hace
Pursuant to the Global Settlement Agreement, and as more fully set forth therein (a) JPMC or its designee will be deemed to be the sole legal, equitable and beneficial owner of the Trust Preferred Securities, (b) the WMI Entities will be deemed to have sold, transferred, and assigned any and all rig
COOP
236T568 236T568 18 minutos hace
Whoaaaaa. Potential great news 

https://x.com/SpencerGuard/status/1861662030723232225?s=19
knrorrel knrorrel 19 minutos hace
question and thanks for the answer.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175447011
nowwhat2 nowwhat2 19 minutos hace
Just to reiterate

https://investorshub.advfn.com/uimage/uploads/2024/11/27/lwlnhBTC_111111_26_CAPT_1030pm_IMPORT_UTMOST.jpg

93,413





https://investorshub.advfn.com/uimage/uploads/2024/11/26/tj[[ebtc_111111_26_30d_833pm_CHAN_
BTCUSD
knrorrel knrorrel 20 minutos hace
question and thanks for the answer.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175447011
knrorrel knrorrel 21 minutos hace
Are there any opinions: "Is the Quantum Hype over or is this the usual breather of a few days before it continues to rise?" ...... I'm itching to buy $QBTS and $QSI back now. After the two-day decline, both stocks have fantastic catalyst patents and should have a great future..... what do you think?
QBTS QSI
knrorrel knrorrel 22 minutos hace
Are there any opinions: "Is the Quantum Hype over or is this the usual breather of a few days before it continues to rise?" ...... I'm itching to buy $QBTS and $QSI back now. After the two-day decline, both stocks have fantastic catalyst patents and should have a great future..... what do you think?
QBTS QSI
Zorax Zorax 23 minutos hace
and the Congress may by law provide for the case wherein neither a President elect nor a Vice President elect shall have qualified, declaring who shall then act as PresidentWhy not the candidate's opponent? The runner up Harris?
dinogreeves dinogreeves 24 minutos hace
Analyst are going to digest this 8K tomorrow and depending on what they read into it and how they pick it apart or they already knew? like you said, "So we watch". Wasn't there loan extension a week ago, then abruptly decided to pay them off. Something is going on behind the scenes.
SMCI
jay_tee jay_tee 24 minutos hace
How am I the worst person to respond to anything? lol I guess Maryland should just blindly listen to only the thoughts of folks crossing their fingers hoping and wishing ...Seamus does right by us all... I mean it's 10 yrs so it's way past due. 
RNVA
mascale mascale 27 minutos hace
Actual message board subject, versus posted, noted low literacy levels. (Nestle is OTC, e.g.) "Hiru audit has been in process for several weeks, including financials and re-audit of assets. Hiru is not yet a complex conglomerate so timelines measured in days and weeks are applicable. Most recently.
HIRU
dinogreeves dinogreeves 28 minutos hace
Yeah LJ, I saw that video. I believe sometime tomorrow we will have analyst chiming in. Anyone that pays off loans/notes they are very credit worthy. Any public company that pays off notes, institutional investors welcome that with open arms and yes there was filing of some sort referencing B of
SMCI
RuudSaltis RuudSaltis 36 minutos hace
Shorts are down 180.000 en institutional is little bit more up since beginning of the day! (Fintel) So everybody is taking positions! Indeed Xena change is imminent!
LWLG
Zorax Zorax 38 minutos hace
As all those paid assholes behind him stay on their phones.
lovethatgreen lovethatgreen 40 minutos hace
Asking folks not to speculate when bones are thrown out about major defense contractors and regional bell companies is like handing a glass of water to guy that just came off the desert and tell him not to drink it there will also be ice in a hour or two .

Then there is follow up m
MONI